These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 32097997)

  • 21. The role of mitochondria in metabolic disease: a special emphasis on heart dysfunction.
    Federico M; De la Fuente S; Palomeque J; Sheu SS
    J Physiol; 2021 Jul; 599(14):3477-3493. PubMed ID: 33932959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of reactive oxygen species in the diabetic heart. Roles of mitochondria and NADPH oxidase.
    Teshima Y; Takahashi N; Nishio S; Saito S; Kondo H; Fukui A; Aoki K; Yufu K; Nakagawa M; Saikawa T
    Circ J; 2014; 78(2):300-6. PubMed ID: 24334638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective insulin signaling and mitochondrial dynamics in diabetic cardiomyopathy.
    Westermeier F; Navarro-Marquez M; López-Crisosto C; Bravo-Sagua R; Quiroga C; Bustamante M; Verdejo HE; Zalaquett R; Ibacache M; Parra V; Castro PF; Rothermel BA; Hill JA; Lavandero S
    Biochim Biophys Acta; 2015 May; 1853(5):1113-8. PubMed ID: 25686534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction.
    Baseler WA; Dabkowski ER; Williamson CL; Croston TL; Thapa D; Powell MJ; Razunguzwa TT; Hollander JM
    Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R186-200. PubMed ID: 21048079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology.
    Heather LC; Gopal K; Srnic N; Ussher JR
    Diabetes; 2024 May; 73(5):659-670. PubMed ID: 38387045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The vulnerable myocardium. Diabetic cardiomyopathy.
    Bugger H; Bode C
    Hamostaseologie; 2015; 35(1):17-24. PubMed ID: 25408270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac mitochondrial energy metabolism in heart failure: Role of cardiolipin and sirtuins.
    Dolinsky VW; Cole LK; Sparagna GC; Hatch GM
    Biochim Biophys Acta; 2016 Oct; 1861(10):1544-54. PubMed ID: 26972373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3.
    Bugger H; Boudina S; Hu XX; Tuinei J; Zaha VG; Theobald HA; Yun UJ; McQueen AP; Wayment B; Litwin SE; Abel ED
    Diabetes; 2008 Nov; 57(11):2924-32. PubMed ID: 18678617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced glycation end products receptor RAGE controls myocardial dysfunction and oxidative stress in high-fat fed mice by sustaining mitochondrial dynamics and autophagy-lysosome pathway.
    Yu Y; Wang L; Delguste F; Durand A; Guilbaud A; Rousselin C; Schmidt AM; Tessier F; Boulanger E; Neviere R
    Free Radic Biol Med; 2017 Nov; 112():397-410. PubMed ID: 28826719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic abnormalities of the heart in type II diabetes.
    Amaral N; Okonko DO
    Diab Vasc Dis Res; 2015 Jul; 12(4):239-48. PubMed ID: 25941161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise.
    Schilling JD
    Antioxid Redox Signal; 2015 Jun; 22(17):1515-26. PubMed ID: 25761843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy.
    Fillmore N; Mori J; Lopaschuk GD
    Br J Pharmacol; 2014 Apr; 171(8):2080-90. PubMed ID: 24147975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial dynamics in diabetic cardiomyopathy.
    Galloway CA; Yoon Y
    Antioxid Redox Signal; 2015 Jun; 22(17):1545-62. PubMed ID: 25738230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SIRT6: A potential therapeutic target for diabetic cardiomyopathy.
    Wu T; Qu Y; Xu S; Wang Y; Liu X; Ma D
    FASEB J; 2023 Aug; 37(8):e23099. PubMed ID: 37462453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Of mice and men: modeling cardiovascular complexity in diabetes. Focus on "Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart".
    Patel HH; McDonough AA
    Am J Physiol Cell Physiol; 2014 Sep; 307(6):C497-8. PubMed ID: 25031018
    [No Abstract]   [Full Text] [Related]  

  • 36. Myocardial metabolism in diabetic cardiomyopathy: potential therapeutic targets.
    Sung MM; Hamza SM; Dyck JR
    Antioxid Redox Signal; 2015 Jun; 22(17):1606-30. PubMed ID: 25808033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits.
    Zhang X; Zhang Z; Yang Y; Suo Y; Liu R; Qiu J; Zhao Y; Jiang N; Liu C; Tse G; Li G; Liu T
    Cardiovasc Diabetol; 2018 Dec; 17(1):160. PubMed ID: 30591063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial membrane transporters and metabolic switch in heart failure.
    Kumar V; Santhosh Kumar TR; Kartha CC
    Heart Fail Rev; 2019 Mar; 24(2):255-267. PubMed ID: 30535838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial centrality in heart failure.
    Marín-García J; Goldenthal MJ
    Heart Fail Rev; 2008 Jun; 13(2):137-50. PubMed ID: 18185992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis.
    Qi B; He L; Zhao Y; Zhang L; He Y; Li J; Li C; Zhang B; Huang Q; Xing J; Li F; Li Y; Ji L
    Diabetologia; 2020 May; 63(5):1072-1087. PubMed ID: 32072193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.